Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProtTech is a specialized biotechnology company providing high-end proteomics and protein analytical services to the global pharmaceutical and biopharmaceutical industries. Founded in 2003, the company leverages advanced mass spectrometry technologies to offer comprehensive protein characterization, including protein identification, sequence verification, and post-translational modification analysis. ProtTech is particularly recognized for its expertise in biosimilar analysis, disulfide bond mapping, and host cell protein (HCP) identification. By integrating proprietary bioinformatics tools with state-of-the-art instrumentation, the company supports drug discovery and the development of complex biologics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProtTech.